Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress

Due to the overexpression or amplification of human epidermal growth factor receptor 2 (HER2) with poor prognosis in a myriad of human tumors, recent studies have focused on HER2-targeted therapies. Deregulation in HER2 signaling pathways is accompanied by sustained tumor cells growth concomitant wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Budi, Hendrik Setia, Ahmad, Firdaus Nuri, Achmad, Harun, Ansari, Mohammad Javed, Mikhailova, Maria Vladimirovna, Suksatan, Wanich, Chupradit, Supat, Shomali, Navid, Marofi, Faroogh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800342/
https://www.ncbi.nlm.nih.gov/pubmed/35093187
http://dx.doi.org/10.1186/s13287-022-02719-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800342/
https://www.ncbi.nlm.nih.gov/pubmed/35093187
http://dx.doi.org/10.1186/s13287-022-02719-0

Ejemplares similares